|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.
|
|
2
|
Mills IG: Maintaining and reprogramming
genomic androgen receptor activity in prostate cancer. Nat Rev
Cancer. 14:187–198. 2014. View
Article : Google Scholar
|
|
3
|
Dai C, Dehm SM and Sharifi N: Targeting
the androgen signaling axis in prostate cancer. J Clin Oncol.
41:4267–4278. 2023. View Article : Google Scholar
|
|
4
|
Claessens LA and Vertegaal ACO: SUMO
proteases: From cellular functions to disease. Trends Cell Biol.
34:901–912. 2024. View Article : Google Scholar
|
|
5
|
Chang HM and Yeh ETH: SUMO: From bench to
bedside. Physiol Rev. 100:1599–1619. 2020. View Article : Google Scholar
|
|
6
|
Kaikkonen S, Jääskeläinen T, Karvonen U,
Rytinki MM, Makkonen H, Gioeli D, Paschal BM and Palvimo JJ:
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented
SUMOylation of androgen receptor and modulates gene responses in
prostate cancer cells. Mol Endocrinol. 23:292–307. 2009. View Article : Google Scholar
|
|
7
|
Xu G, Wu J, Zhou L, Chen B, Sun Z, Zhao F
and Tao Z: Characterization of the small RNA transcriptomes of
androgen dependent and independent prostate cancer cell line by
deep sequencing. PLoS One. 5:e155192010. View Article : Google Scholar
|
|
8
|
Liu W, Wang X, Wang Y, Dai Y, Xie Y, Ping
Y, Yin B, Yu P, Liu Z, Duan X, et al: SGK1 inhibition-induced
autophagy impairs prostate cancer metastasis by reversing EMT. J
Exp Clin Cancer Res. 37:732018. View Article : Google Scholar
|
|
9
|
Liu W, Wang X, Wang Y, Dai Y, Xie Y, Ping
Y, Yin B, Yu P, Liu Z, Duan X, et al: SGK1 inhibition induces
autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J
Cancer. 117:1139–1153. 2017. View Article : Google Scholar
|
|
10
|
Liang D, Feng Y, Zandkarimi F, Wang H,
Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR and Jiang X: Ferroptosis
surveillance independent of GPX4 and differentially regulated by
sex hormones. Cell. 186:2748–2764.e2722. 2023. View Article : Google Scholar
|
|
11
|
Chang KH, Li R, Kuri B, Lotan Y, Roehrborn
CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, et al: A
gain-of-function mutation in DHT synthesis in castration-resistant
prostate cancer. Cell. 154:1074–1084. 2013. View Article : Google Scholar
|
|
12
|
Higano CS, Beer TM, Taplin ME, Efstathiou
E, Hirmand M, Forer D and Scher HI: Long-term safety and antitumor
activity in the phase 1–2 study of enzalutamide in pre- and
post-docetaxel castration-resistant prostate cancer. Eur Urol.
68:795–801. 2015. View Article : Google Scholar
|
|
13
|
Claessens LA, Verlaan-de Vries M, de Graaf
IJ and Vertegaal ACO: SENP6 regulates localization and nuclear
condensation of DNA damage response proteins by group
deSUMOylation. Nat Commun. 14:58932023. View Article : Google Scholar
|
|
14
|
Lin H, Suzuki K, Smith N, Li X, Nalbach L,
Fuentes S, Spigelman AF, Dai XQ, Bautista A, Ferdaoussi M, et al: A
role and mechanism for redox sensing by SENP1 in β-cell responses
to high fat feeding. Nat Commun. 15:3342024. View Article : Google Scholar
|
|
15
|
Wei M, Huang X, Liao L, Tian Y and Zheng
X: SENP1 decreases RNF168 phase separation to promote DNA damage
repair and drug resistance in colon cancer. Cancer Res.
83:2908–2923. 2023. View Article : Google Scholar
|
|
16
|
Zhang Y, Wei H, Zhou Y, Li Z, Gou W, Meng
Y, Zheng W, Li J, Li Y and Zhu W: Identification of potent SENP1
inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and
overcome platinum drug resistance in ovarian cancer. Clin Transl
Med. 11:e6492021. View
Article : Google Scholar
|
|
17
|
Xiao M, Bian Q, Lao Y, Yi J, Sun X, Sun X
and Yang J: SENP3 loss promotes M2 macrophage polarization and
breast cancer progression. Mol Oncol. 16:1026–1044. 2021.
View Article : Google Scholar
|
|
18
|
Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen
H, Yu Y, Ma S, Xu Y, Li Z, et al: SENP5 promotes homologous
recombination-mediated DNA damage repair in colorectal cancer cells
through H2AZ deSUMOylation. J Exp Clin Cancer Res. 42:2342023.
View Article : Google Scholar
|
